Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Fluoxetine: antidepressant and a possible new drug for the treatment of obesity


Genetically fattened Zucker fa/fa rats
© University of the Basque Country

The Department of Nutrition and Bromatology of the Faculty of Pharmacy of Gasteiz, University of the Basque Country, is studying the action mechanism of fluoxetine in genetically fattened rats (Zucker fa/fa). Due to fluoxetine, those rats eat 50 % less. Therefore, the bodies put on less weight and the size of different fat tissues is reduced.
Antidepressants of the type of fluoxetine reduce appetite. More exactly, fluoxetine affects on neuropeptides that regulate appetite. Hence, it is believed that fluoxetine can be used to treat obesity.

After studying the action-mechanism of fluoxetine it has been observed that it reduces the quantity of Y neuropeptide. That peptide is orexigen, it causes appetite. The fluoxetine does hinders the trasport of that peptide, and so appetite is reduced.

That result has lead the scientists of the faculty of pharmacy to study the effect of fluoxetine on melanocortins. Melanocortins are important neuropeptides that control how many food is consumed. Now they are studying the changes that may occur in the operative system of melanocortins, both in MC4-R melanocortin receptors and in a-MSH (alfa melanocyte stimulating hormones) .

Hunger and neuropeptides

Appetite is a feeling that is created in the hypothalamus and its regulation is a complex process that depends on the regulation of neuropeptides, neurotransmitters and several hormones. In that process two types of neuropeptides must be taken into account: orexigens or appetite stimulants and anorexigens or reducers of appetite.

Some of the well-known orexigens are Y neuropeptide, some opioid peptides, endogenous cannabinoid, etc. Among anorexigens CRF (corticotropin releasing factor), CART (cocaine and amphetamine related transcript), melanocortin, galanin and cytokines. All those neuropeptides have effect on the hypothalamus and their interaction causes hunger and satiety.

It is believed that those neuropeptides could be the responsible of disorders such as obesity, anorexia nervosa and bulimia. Nowadays there is no appropriate drug to treat those disorders and some of the cures that have been used are very dangerous and harmful for the health, for example amphetamines. According to the result of this research, who knows if fluoxetine, apart from being an antidepressant, may become a secure drug to treat obesity.

Garazi Andonegi | alfa
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

Im Focus: Radar for navigation support from autonomous flying drones

At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.

Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

International Virtual Reality Conference “IEEE VR 2018” comes to Reutlingen, Germany

08.03.2018 | Event News

Latest News

Wandering greenhouse gas

16.03.2018 | Earth Sciences

'Frequency combs' ID chemicals within the mid-infrared spectral region

16.03.2018 | Physics and Astronomy

Biologists unravel another mystery of what makes DNA go 'loopy'

16.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>